Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
We assessed the relationships between the GLP-1 RAs users and the control group concerning primary and secondary outcomes using the Cox proportional hazards model, which allowed us to calculate adjusted hazard ratios (aHRs) 51
Injection of 100 mg/kg/day of EGCG notably suppresses the hepatic Nrf2 pathway (231)
Academic and industry research consistently shows that first-to-file generics can generate 60-80% of a products total generic market profit during the exclusivity period, because they can price at 10-20% below the brand rather than the 70-90% discounts that become necessary once five or more generics enter the market simultaneously
Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, et al
Take our 3-minute quiz today to see if you are a candidate for Shapely
A recent multicenter international phase II RCT (GOLDEN-505) in noncirrhotic biopsy-proven NASH patients showed an insignificant difference in NASH resolution without fibrosis progression between the elafibranor and placebo groups at 52 weeks of treatment
US$ 29.59
US$ 25.05
US$ 28.34
US$ 24.98
